Cyanidin-3-O-β-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARγ activity in human omental adipocytes

Diabetes

Volumn 60, Issue 9, 2011, Pages 2234-2244

  Scazzocchio, Beatrice ^a   Varì, Rosaria ^a   Filesi, Carmelina ^a   D'Archivio, Massimo ^a   Santangelo, Carmela ^a   Giovannini, Claudio ^a   Iacovelli, Annunziata ^b   Silecchia, Gianfranco ^c   Volti, Giovanni Li ^d,e   Galvano, Fabio ^d   Masella, Roberta ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Fabia Mater Hospital   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYANIDIN 3 GLUCOSIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTOCATECHUIC ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN LIKE ACTIVITY; MOUSE; NONHUMAN; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; ANTHOCYANINS; CELLS, CULTURED; GENE EXPRESSION; GLUCOSIDES; HUMANS; HYDROXYBENZOIC ACIDS; INSULIN; MICE; OMENTUM; PPAR GAMMA;

EID: 80052903790     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1461     Document Type: Article

References (50)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428 (Pubitemid 40523737)
3. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008;299:2287-2293 (Pubitemid 351724395)
4. Tsuzura S, Ikeda Y, Suehiro T, et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004;53:297-302 (Pubitemid 38684688)
5. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998;98:1487-1494 (Pubitemid 28481664)
6. Weinbrenner T, Schröder H, Escurriol V, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr 2006;83:30-35; quiz 181-182
7. Mazière C, Morlière P, Santus R, et al. Inhibition of insulin signaling by oxidized low density lipoprotein. Protective effect of the antioxidant vitamin E. Atherosclerosis 2004;175:23-30
8. Masella R, Varì R, D'Archivio M, et al. Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation. FEBS Lett 2006;580:2421-2429 (Pubitemid 44389367)
9. D'Archivio M, Scazzocchio B, Filesi C, et al. Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes. FEBS Lett 2008;582:2291-2298
10. Scazzocchio B, Varì R, D'Archivio M, et al. Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. J Lipid Res 2009;50:832-845
11. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537-1545 (Pubitemid 44324105)
12. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946 (Pubitemid 32756432)
13. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89
14. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58 (Pubitemid 34756495)
15. Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003;52:1655-1663 (Pubitemid 36792453)
16. Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998;47:507-514 (Pubitemid 28160438)
17. Badman MK, Flier JS. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007;132:2103-2115 (Pubitemid 46693755)
18. Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2004;89:4312-4319 (Pubitemid 39244431)
19. Biesalski HK. Diabetes preventive components in the Mediterranean diet. Eur J Nutr 2004;43(Suppl. 1):I/26-30
20. Lindström J, Ilanne-Parikka P, Peltonen M, et al.; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679
21. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
22. Saura-Calixto F, Goñi I. Definition of the Mediterranean diet based on bioactive compounds. Crit Rev Food Sci Nutr 2009;49:145-152
23. Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 1993;20:21-29 (Pubitemid 23225364)
24. Kay CD, Mazza G, Holub BJ, Wang J. Anthocyanin metabolites in human urine and serum. Br J Nutr 2004;91:933-942 (Pubitemid 38931457)
25. Kay CD, Mazza GJ, Holub BJ. Anthocyanins exist in the circulation primarily as metabolites in adult men. J Nutr 2005;135:2582-2588 (Pubitemid 43156599)
26. Mazza G, Kay CD. Bioactivity, absorption, and metabolism of anthocyanins. In Recent Advances in Polyphenols Research. Vol. 1. Lattanzio V, Daayf F, Eds. Oxford, Blackwell, 2008, p. 228-262
27. Tsuda T, Horio F, Osawa T. Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett 1999;449:179-182 (Pubitemid 29192901)
28. Vitaglione P, Donnarumma G, Napolitano A, et al. Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J Nutr 2007;137:2043-2048 (Pubitemid 47367263)
29. Cao G, Muccitelli HU, Sánchez-Moreno C, Prior RL. Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. Am J Clin Nutr 2001;73:920-926 (Pubitemid 32405989)
30. Galvano F, La Fauci L, Lazzarino G, et al. Cyanidins: metabolism and biological properties. J Nutr Biochem 2004;15:2-11 (Pubitemid 38050253)
31. Serraino I, Dugo L, Dugo P, et al. Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci 2003;73:1097-1114 (Pubitemid 36724913)
32. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003;133:2125-2130 (Pubitemid 36841527)
33. Seymour EM, Lewis SK, Urcuyo-Llanes DE, et al. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet. J Med Food 2009;12:935-942
34. Xia M, Hou M, Zhu H, et al. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor gamma-liver X receptor alpha-ABCA1 pathway. J Biol Chem 2005;280:36792-36801 (Pubitemid 41587759)
35. Masella R, Varì R, D'Archivio M, et al. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr 2004;134:785-791 (Pubitemid 38456244)
36. Kristensen K, Pedersen SB, Richelsen B. Regulation of leptin by steroid hormones in rat adipose tissue. Biochem Biophys Res Commun 1999;259:624-630 (Pubitemid 29335583)
37. Tanti JF, Cormont M, Grémeaux T, Le Marchand-Brustel Y. Assays of glucose entry, glucose transporter amount, and translocation. Methods Mol Biol 2001;155:157-165
38. Piper RC, Hess LJ, James DE. Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol 1991;260:C570-C580
39. McKeel DW, Jarett L. Preparation and characterization of a plasma membrane fraction from isolated fat cells. J Cell Biol 1970;44:417-432
40. Arai Y, Kojima T, Takayama M, Hirose N. The metabolic syndrome, IGF-1, and insulin action. Mol Cell Endocrinol 2009;299:124-128
41. Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000;105:311-320 (Pubitemid 30094451)
42. Folli F, Saad MJ, Backer JM, Kahn CR. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 1993;92:1787-1794 (Pubitemid 23304544)
43. Adisakwattana S, Charoenlertkul P, Yibchok-Anun S. alpha-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose. J Enzyme Inhib Med Chem 2009;24:65-69
44. Takikawa M, Inoue S, Horio F, Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 2010;140: 527-533
45. Nizamutdinova IT, Jin YC, Chung JI, et al. The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis. Mol Nutr Food Res 2009;53:1419-1429
46. Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 2002;50:7731-7737 (Pubitemid 35453741)
47. Koli R, Erlund I, Jula A, Marniemi J, Mattila P, Alfthan G. Bioavailability of various polyphenols from a diet containing moderate amounts of berries. J Agric Food Chem 2010;58:3927-3932
48. Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WH. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta 2009;405:114-118
49. Tsuda T, Ueno Y, Aoki H, et al. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem Biophys Res Commun 2004;316:149-157 (Pubitemid 38304941)
50. Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 2006;71:1184-1197 (Pubitemid 43357899)